Literature DB >> 9591758

Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events.

J T Grayston.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9591758     DOI： 10.1161/01.cir.97.17.1669

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Chlamydia pneumoniae and atherosclerosis.

Authors:  Y Wong; M E Ward
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

Review 2.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 3.  [Angiology update].

Authors:  C Ranke; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-05-15

4.  Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999.

Authors:  K G Manton; X Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

5.  Prevention of coronary heart disease through treatment of infection with Chlamydia pneumoniae? Estimation of possible effectiveness and costs.

Authors:  C Sanderson; M Kubin
Journal:  Health Care Manag Sci       Date:  2001-12

6.  Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model.

Authors:  Andrei Kutlin; Patricia M Roblin; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 7.  Chlamydia pneumoniae and atherosclerosis.

Authors:  Y K Wong; P J Gallagher; M E Ward
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

8.  Oral azithromycin in extended dosage schedule for chronic, subclinical Chlamydia pneumoniae infection causing coronary artery disease: a probable cure in sight? Results of a controlled preliminary trial.

Authors:  Jaideep Dogra
Journal:  Int J Gen Med       Date:  2012-06-08

Review 9.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.